---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-087555"
form_type: "8-K"
ticker: "HRTX"
cik: "0000818033"
company_name: "HERON THERAPEUTICS, INC. /DE/"
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T03:54:49.680889+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Heron Therapeutics announces 2025 annual meeting results; all proposals approved

## Summary
- Stockholders elected all six director nominees: Collard, Dissanaike, Johnson, Kaseta, Morgan, Waage, each receiving >79M votes for.
- Ratified WithumSmith+Brown as independent auditor for FY2025: 118.6M votes for, 1.0M against.
- Approved non-binding advisory vote on 2024 executive compensation: 79.3M for, 3.5M against.
- Adopted annual frequency for future say-on-pay advisory votes: 80.5M for 1-year, 2.2M for 3-year.

## SEC filing metadata
- accession: 0000950170-25-087555
- form_type: 8-K
- ticker: HRTX
- cik: 0000818033
- company_name: HERON THERAPEUTICS, INC. /DE/
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818033/000095017025087555/0000950170-25-087555-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818033/000095017025087555/hrtx-20250612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-087555
- JSON: https://secwatch.observer/filing/0000950170-25-087555.json
- Plain text: https://secwatch.observer/filing/0000950170-25-087555.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.